Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Mar 2007 06:05 PM
RNS
Holding(s) in Company
16 Mar 2007 05:31 PM
RNS
Holding(s) in Company
16 Mar 2007 01:35 PM
RNS
Holding(s) in Company
15 Mar 2007 08:42 AM
RNS
Acquisition
12 Mar 2007 07:01 AM
RNS
Acq of Oxxon Therapeutics
06 Mar 2007 07:00 AM
RNS
Preliminary Results
28 Feb 2007 11:15 AM
RNS
Total Voting Rights
27 Feb 2007 11:12 AM
RNS
Holding(s) in Company
27 Feb 2007 07:00 AM
RNS
Notice of FY2006 Results
22 Feb 2007 09:36 AM
RNS
Holding(s) in Company
20 Feb 2007 12:45 PM
RNS
Holding(s) in Company
14 Feb 2007 11:04 AM
RNS
Holding(s) in Company
09 Feb 2007 10:55 AM
RNS
Holding(s) in Company
07 Feb 2007 05:49 PM
RNS
Holding(s) in Company
01 Feb 2007 03:18 PM
RNS
Result of EGM
31 Jan 2007 06:04 PM
RNS
Total Voting Rights
24 Jan 2007 03:39 PM
RNS
Holding(s) in Company
24 Jan 2007 07:00 AM
RNS
Transgenic Milestone
16 Jan 2007 07:01 AM
RNS
Publication of Results
10 Jan 2007 07:00 AM
RNS
Phase III Trial of Trovax
04 Jan 2007 04:48 PM
RNS
Total Voting Rights-Amendment
02 Jan 2007 03:47 PM
RNS
Total Voting Rights-Amendment
22 Dec 2006 11:55 AM
RNS
Total Voting Rights
21 Dec 2006 07:00 AM
RNS
GSK Lentivector Licence
19 Dec 2006 05:51 PM
RNS
Holding(s) in Company
19 Dec 2006 07:00 AM
RNS
Licensing Agreement
08 Dec 2006 04:55 PM
RNS
Holding(s) in Company
08 Dec 2006 07:00 AM
RNS
Positive Opinion on Trovax
05 Dec 2006 07:00 AM
RNS
Holding(s) in Company
21 Nov 2006 09:31 AM
RNS
Blocklisting Interim Review
13 Nov 2006 07:00 AM
RNS
Prosavin preclinical data
09 Nov 2006 07:00 AM
RNS
Phase II Results - Trovax
07 Nov 2006 07:00 AM
RNS
Phase III Trial in Trovax
06 Oct 2006 07:00 AM
RNS
Presentation at Conference
02 Oct 2006 07:00 AM
RNS
Gene Therapy for Blindness
25 Sep 2006 02:32 PM
RNS
Holding(s) in Company
20 Sep 2006 10:08 AM
RNS
Holding(s) in Company
07 Sep 2006 10:54 AM
RNS
Interest in Share Options
05 Sep 2006 07:01 AM
RNS
SWOG in phase 2 Trovax trial
05 Sep 2006 07:00 AM
RNS
Interim Results
21 Aug 2006 07:00 AM
RNS
Trovax at Cancer Conference
03 Aug 2006 04:00 PM
RNS
Holding(s) in Company
02 Aug 2006 07:00 AM
RNS
Notice of Interim Results
31 Jul 2006 07:00 AM
RNS
Trovax Update & Clarification
18 Jul 2006 04:09 PM
RNS
Holding(s) in Company
06 Jul 2006 04:31 PM
RNS
Holding(s) in Company
05 Jul 2006 04:54 PM
RNS
Director/PDMR Shareholding
26 Jun 2006 11:43 AM
RNS
Holding(s) in Company
26 Jun 2006 07:00 AM
RNS
Prosavin Patent
21 Jun 2006 07:00 AM
RNS
Piper Jaffray Health Care

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100